VIMTALABS Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > vimtalabs

Technical Analysis

Technical Strength: 3 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 46.2. According to RSI analysis, vimtalabs is marginally weak. 4.0 VIMTALABS RSI Chart
MACD (?) MACD: -1.03 and Signal Line: -0.889. According to MACD analysis, vimtalabs is technically weak. 2.0 VIMTALABS MACD Chart
Simple Moving Average (?) According to simple moving average analysis, vimtalabs is facing resistance at 131 and support level is at 123.93. 3.0 VIMTALABS Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, vimtalabs is facing resistance at 131 and support level is at 123.952. 3.0 VIMTALABS Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.333. 5.0 VIMTALABS Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA VIMTALABS Fibonacci Retracement Chart
Average True Range (?) ATR: 5.2 NA VIMTALABS Average True Range Chart
Average Directional Index (?) ADX is 24.3 which means VIMTALABS is in a trading range and there is no trend. NA VIMTALABS Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 17, 2017
Open Price 128.4
High Price 130.4
Low Price 128.4
Close Price 129.0
Absolute Change 0.6
Percentage Change 0.467%
Weekly Change -1.04%
Monthly Change -1.49%
Yearly Change 32%
52-week high 164.3
52-week low 88.4
Corporate Actions
ExDate Purpose
August 25, 2016 AGM/DIV RE 1/- PER SHARE
August 06, 2015 AGM/DIV-RE 1 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.959
Confidence in Beta3.35%
Market Capital Rs. 285.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 3.57
TTM Price-to-Earnings (P/E) Ratio 36.1
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 17 October 2017: Deliverable Quantity:0 NA VIMTALABS Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 16 October 2017: Daily Volatility:0.4623 NA VIMTALABS Annualized Daily Volatility (Spot Price) Chart


October 10, 2017 VResignationVimta Labs Limited has informed the Exchange regarding Resignation of Mr Dr Subba Rao Pavuluri as Non- Executive Independent Director of the company w.e.f. October 10, 2017.
October 03, 2017 VCredit RatingVimta Labs Limited has informed the Exchange regarding Credit Rating
See all Announcements

Board Meetings

Date Meeting Date Purpose
April 10, 2017 April 22, 2017 iResults/Dividendinter-alia, to consider, approve and take on record the Audited Financial Results for the 4th Quarter and for the Financial year ended March 31, 2017. Further that the Board proposed to consider recommendation of Dividend, if any in the above said meeting.
January 30, 2017 February 11, 2017 IResultsInter-alia, to consider, approve and take on record the Unaudited Financial Results for the 3rd Quarter ended December 31, 2016.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 126.1 Rs. 127.3 Rs. 128.1 Rs. 129.3 Rs. 130.1 Rs. 131.3 Rs. 132.1